Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery MUC5AC
Path
Created with Sketch.
Go to MUC5AC Normal Tissue Gallery
Go back to Product Page
Colon- Colorectal adenocarcinoma containing areas with diffuse MUC5AC positivity next to areas with rather few interspersed MUC5AC positive cells.
Colon- Colorectal adenocarcinoma containing areas with diffuse MUC5AC positivity next to areas with rather few interspersed MUC5AC positive cells.
Colon- Colorectal adenocarcinoma with few scattered MUC5AC positive cells. The distribution of positive cells mirrors the MUC5AC expression pattern in normal colon mucosa.
Colon- Colorectal adenocarcinoma with few scattered MUC5AC positive cells. The distribution of positive cells mirrors the MUC5AC expression pattern in normal colon mucosa.
Colon- Colorectal adenocarcinoma with weak to moderate MUC5AC immunostaining in about 25% of the tumor cells
Colon- Colorectal adenocarcinoma with weak to moderate MUC5AC immunostaining in about 25% of the tumor cells
Colon- Focal MUC5AC positivity in a cholangiocellular carcinoma also showing focal squamoid differentiation
Colon- Focal MUC5AC positivity in a cholangiocellular carcinoma also showing focal squamoid differentiation
Colon- Focal MUC5AC positivity in a colorectal adenocarcinoma
Colon- Focal MUC5AC positivity in a colorectal adenocarcinoma
Liver- Moderate MUC5AC positivity in about 50% of the tumor cells in a cholangiocellular carcinoma
Colon- Moderate MUC5AC positivity in about 50% of the tumor cells in a cholangiocellular carcinoma of the liver
Colon- MUC5AC negative colorectal adenocarcinoma
Colon- MUC5AC negative colorectal adenocarcinoma
Colon- Scattered MUC5AC positive cells in a colorectal adenocarcinoma. The distribution of positive cells is comparable to the MUC5AC expression pattern in normal colon mucosa.
Colon- Scattered MUC5AC positive cells in a colorectal adenocarcinoma. The distribution of positive cells is comparable to the MUC5AC expression pattern in normal colon mucosa.
Colon- Strong diffuse MUC5AC immunostaining in a colorectal adenocarcinoma.
Colon- Strong diffuse MUC5AC immunostaining in a colorectal adenocarcinoma.
Colon- Strong diffuse MUC5AC positivity in a colorectal adenocarcinoma exhibiting an intestinal type growth pattern.
Colon- Strong diffuse MUC5AC positivity in a colorectal adenocarcinoma exhibiting an intestinal type growth pattern.
Colon- strong MUC5AC expression in a mucinous colorectal adenocarcinoma.
Colon- strong MUC5AC expression in a mucinous colorectal adenocarcinoma.
Colon- Weak to moderate MUC5AC immunostaining in about 50% of the tumor cells of a colorectal adenocarcinoma showing a solid growth pattern.
Colon- Weak to moderate MUC5AC immunostaining in about 50% of the tumor cells of a colorectal adenocarcinoma showing a solid growth pattern.
Uterus- Strong diffuse MUC5AC positivity in an endometroid endometrium cancer.
Uterus- Strong diffuse MUC5AC positivity in an endometroid endometrium cancer.
Lung- adenocarcinoma with very few scattered MUC5AC positive cells.
Lung- adenocarcinoma with very few scattered MUC5AC positive cells.
Lung- Few scattered MUC5AC positive cells in a lepidic adenocarcinoma.
Lung- Few scattered MUC5AC positive cells in a lepidic adenocarcinoma.
Lung- Focal MUC5AC expression in an adenocarcinoma.
Lung- Focal MUC5AC expression in an adenocarcinoma.
Lung- Strong diffuse MUC5AC positivity in an adenocarcinoma.
Lung- Strong diffuse MUC5AC positivity in an adenocarcinoma.
Ovary - Scattered MUC5AC positive cells in a serous high-grade carcinoma.
Ovary – Scattered MUC5AC positive cells in a serous high-grade carcinoma.
Urinary bladder- Moderate to strong MUC5AC immunostaining in about 50% of cells of a muscle-invasive urothelium carcinoma.
Urinary bladder- Moderate to strong MUC5AC immunostaining in about 50% of cells of a muscle invasive urothelium carcinoma.
Urinary bladder- MUC5AC positivity in a very small fraction of tumor cells in a muscle-invasive urothelium carcinoma.
Urinary bladder- MUC5AC positivity in a very small fraction of tumor cells in a muscle invasive urothelium carcinoma.
Urinary bladder- Muscle-invasive urothelial carcinoma (pT2) with intense MUC5AC positivity in about 80% of tumor cells.
Urinary bladder- Muscle-invasive urothelial carcinoma (pT2) with intense MUC5AC positivity in about 80% of tumor cells.
Pancreas- Intense MUC5AC staining in all cells of a ductal adenocarcinoma. Adjacent normal pancreatic tissue stains negative.
Pancreas- Intense MUC5AC staining in all cells of a ductal adenocarcinoma. Adjacent normal pancreatic tissue stains negative.
Pancreas- Moderate intensity MUC5AC positivity in a ductal adenocarcinoma (90% of tumor cells).
Pancreas- Moderate intensity MUC5AC positivity in a ductal adenocarcinoma (90% of tumor cells).
Pancreas- MUC5AC positivity in about 80% of tumor cells in a ductal adenocarcinoma. A normal excretory duct stains negative.
Pancreas- MUC5AC positivity in about 80% of tumor cells in a ductal adenocarcinoma. A normal excretory duct stains negative.
Pancreas- Strong diffuse MUC5AC immunostaining in a ductal adenocarcinoma.
Pancreas- Strong diffuse MUC5AC immunostaining in a ductal adenocarcinoma.
Stomach- Mucinous adenocarcinoma with intense MUC5AC positivity of all tumor cells.
Stomach- Mucinous adenocarcinoma with intense MUC5AC positivity of all tumor cells.
Stomach- Strong MUC5AC immunostaining in a gastric adenocarcinoma (100% of tumor cells)
Stomach- Strong MUC5AC immunostaining in a gastric adenocarcinoma (100% of tumor cells)
Stomach- Strong MUC5AC positivity in a diffuse type gastric adenocarcinoma.
Stomach- Strong MUC5AC positivity in a diffuse type gastric adenocarcinoma.
Stomach- Strong MUC5AC positivity in an intestinal type gastric adenocarcinoma.
Stomach- Strong MUC5AC positivity in an intestinal type gastric adenocarcinoma.
Stomach- Variable levels of MUC5AC expression in the cells of a gastric adenocarcinoma.
Stomach- Variable levels of MUC5AC expression in the cells of a gastric adenocarcinoma.
Pancreas: Strong diffuse MUC5AC immunostaining in an adenocarcinoma of the ampulla of Vater.
Pancreas: Strong diffuse MUC5AC immunostaining in an adenocarcinoma of the ampulla of Vater.
Ovary: Strong MUC5AC immunostaining in about 80% of the cells in a mucinous carcinoma.
Ovary: Strong MUC5AC immunostaining in about 80% of the cells in a mucinous carcinoma.